-+ 0.00%
-+ 0.00%
-+ 0.00%

*Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195M

Dow Jones·06/18/2026 12:01:00

Please log in to view news